PAR Equity Snapshot

ABVX Weekly Equity Report

ABIVAX Société Anonyme

Interactive chart JSON snapshot
Latest Close 85.05 EUR 12 Jun 2026
1W Return -3.2% latest completed week
4W Return -14.1% short-term follow-through
12W Return -22.3% quarterly tape
Trend Breadth 82.7% 43 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
Company Brief

What the company does

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Snapshot

What the weekly tape is saying

ABVX closed the latest completed week at 85.05 EUR. The 4-week return is -14.1% and the 12-week return is -22.3%. Trend Signal is inactive, Market Dynamics is -0.60. Setup signature: Risk-first tape with a 26/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -16.8%
Volume 0.7x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 45 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 42 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 37 Relative leadership and short-term RS change.
Volume 29 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
102.3 EUR
Vs Trend Line
-16.8%
Fair Value
34.93 EUR
Vs Fair Value
143.5%
52W High
132.0 EUR
52W Low
5.12 EUR
Drawdown
-35.6%
Range Position
63.0%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -3.2%
4W -14.1%
12W -22.3%
26W -21.4%
52W 1368.9%

Trend read

Active Streak
0 weeks
52W Active Weeks
43
52W Active Breadth
82.7%
Sector Scope
FR Healthcare
Sector Rank
56 of 76
Sector Percentile
26.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.60
4W MD Change
41.5%
Relative Strength
-1.56
4W RS Change
-105.0%
Expectation
Undecided
Probability
49.95%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.0M
13W Average
1.5M
52W Average
910.4K
Vs 13W
0.7x
Vs 52W
1.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
10.6%
52W Volatility
77.4%
Upside Weeks
32
Downside Weeks
20
Downside Breadth
38.5%
Avg Gain / Loss
25.6% / -7.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
PAR
Country
FR
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
9.1B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 85.05 EUR -3.2% 102.3 EUR 34.93 EUR -0.60 -1.56 1.0M Off
5 Jun 2026 87.85 EUR -22.5% 102.6 EUR 34.49 EUR -0.50 5.16 4.3M Off
29 May 2026 113.4 EUR 7.1% 102.6 EUR 34.02 EUR -0.42 38.89 5.2M On
22 May 2026 105.9 EUR 6.9% 101.8 EUR 33.41 EUR -0.87 34.19 680.0K Off
15 May 2026 99.05 EUR -6.1% 100.9 EUR 32.85 EUR -1.03 31.31 536.8K Off
8 May 2026 105.5 EUR 9.4% 100.3 EUR 32.33 EUR -0.96 40.45 787.9K On
1 May 2026 96.45 EUR 0.5% 99.38 EUR 31.77 EUR -1.06 31.71 314.5K On
24 Apr 2026 96.00 EUR -8.3% 98.57 EUR 31.25 EUR -1.06 33.55 532.9K On
17 Apr 2026 104.7 EUR -3.0% 97.71 EUR 30.73 EUR -1.10 44.48 608.6K On
10 Apr 2026 107.9 EUR 6.4% 96.56 EUR 30.16 EUR -1.01 55.97 441.8K On
3 Apr 2026 101.4 EUR 13.7% 95.32 EUR 29.53 EUR -1.03 56.48 549.4K On
27 Mar 2026 89.20 EUR -18.5% 94.49 EUR 28.94 EUR -0.99 46.48 905.1K On
20 Mar 2026 109.4 EUR 8.1% 93.81 EUR 28.41 EUR -0.93 85.38 3.6M On
13 Mar 2026 101.2 EUR 7.7% 92.38 EUR 27.75 EUR -1.06 71.93 858.5K On